{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:12:25Z","timestamp":1794435145146,"version":"4.9.1"},"reference-count":47,"publisher":"American Association for Cancer Research (AACR)","issue":"21","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Genetic variants that increase breast cancer risk can be rare or common. This study tests whether the genetic risk stratification of breast cancer by rare and common variants in established loci can discriminate tumors with different biology, patient survival, and mode of detection. Multinomial logistic regression tested associations between genetic risk load [protein-truncating variant (PTV) carriership in 31 breast cancer predisposition genes\u2014or polygenic risk score (PRS) using 162 single-nucleotide polymorphisms], tumor characteristics, and mode of detection (OR). Ten-year breast cancer\u2013specific survival (HR) was estimated using Cox regression models. In this unselected cohort of 5,099 patients with breast cancer diagnosed in Sweden between 2001 and 2008, PTV carriers (n = 597) were younger and associated with more aggressive tumor phenotypes (ER-negative, large size, high grade, high proliferation, luminal B, and basal-like subtype) and worse outcome (HR, 1.65; 1.16\u20132.36) than noncarriers. After excluding 92 BRCA1\/2 carriers, PTV carriership remained associated with high grade and worse survival (HR, 1.76; 1.21\u20132.56). In 5,007 BRCA1\/2 noncarriers, higher PRS was associated with less aggressive tumor characteristics (ER-positive, PR-positive, small size, low grade, low proliferation, and luminal A subtype). Among patients with low mammographic density (&amp;lt;25%), non-BRCA1\/2 PTV carriers were more often interval than screen-detected breast cancer (OR, 1.89; 1.12\u20133.21) than noncarriers. In contrast, higher PRS was associated with lower risk of interval compared with screen-detected cancer (OR, 0.77; 0.64\u20130.93) in women with low mammographic density. These findings suggest that rare and common breast cancer susceptibility loci are differentially associated with tumor characteristics, survival, and mode of detection.<\/jats:p>\n                  <jats:p>Significance: These findings offer the potential to improve screening practices for breast cancer by providing a deeper understanding of how risk variants affect disease progression and mode of detection. Cancer Res; 78(21); 6329\u201338. \u00a92018 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-18-1018","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T03:44:44Z","timestamp":1541043884000},"page":"6329-6338","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Differential Burden of Rare and Common Variants on Tumor Characteristics, Survival, and Mode of Detection in Breast Cancer"],"prefix":"10.1158","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8587-7511","authenticated-orcid":false,"given":"Jingmei","family":"Li","sequence":"first","affiliation":[{"name":"1Human Genetics, Genome Institute of Singapore, Singapore, Singapore."},{"name":"2Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore."},{"name":"3Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3201-6416","authenticated-orcid":false,"given":"Emilio","family":"Ugalde-Morales","sequence":"additional","affiliation":[{"name":"3Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Xiong","family":"Wen","sequence":"additional","affiliation":[{"name":"4Cancer Research Malaysia, Sime Darby Medical Centre, Selangor, Subang Jaya, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4516-7421","authenticated-orcid":false,"given":"Brennan","family":"Decker","sequence":"additional","affiliation":[{"name":"5Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, NIH, Bethesda, Maryland."},{"name":"6Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts."},{"name":"7Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8135-4270","authenticated-orcid":false,"given":"Mikael","family":"Eriksson","sequence":"additional","affiliation":[{"name":"3Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Torstensson","sequence":"additional","affiliation":[{"name":"8AstraZeneca Nordic-Baltic, S\u00f6dert\u00e4lje, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene Nordahl","family":"Christensen","sequence":"additional","affiliation":[{"name":"8AstraZeneca Nordic-Baltic, S\u00f6dert\u00e4lje, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6651-7166","authenticated-orcid":false,"given":"Alison M.","family":"Dunning","sequence":"additional","affiliation":[{"name":"7Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8677-2225","authenticated-orcid":false,"given":"Jamie","family":"Allen","sequence":"additional","affiliation":[{"name":"7Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Luccarini","sequence":"additional","affiliation":[{"name":"7Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A.","family":"Pooley","sequence":"additional","affiliation":[{"name":"7Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Simard","sequence":"additional","affiliation":[{"name":"9Genomics Center, Centre Hospitalier Universitaire de Qu\u00e9bec-Universit\u00e9 Laval Research Center, Canada Research Chair in Oncogenetics, Universit\u00e9 Laval, Quebec City, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1214-8080","authenticated-orcid":false,"given":"Leila","family":"Dorling","sequence":"additional","affiliation":[{"name":"7Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas F.","family":"Easton","sequence":"additional","affiliation":[{"name":"7Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0444-590X","authenticated-orcid":false,"given":"Soo Hwang","family":"Teo","sequence":"additional","affiliation":[{"name":"4Cancer Research Malaysia, Sime Darby Medical Centre, Selangor, Subang Jaya, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5640-9126","authenticated-orcid":false,"given":"Per","family":"Hall","sequence":"additional","affiliation":[{"name":"3Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden."},{"name":"10Department of Oncology, S\u00f6dersjukhuset, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Czene","sequence":"additional","affiliation":[{"name":"3Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"key":"2022061706060642000_bib1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2217\/fon.09.29","article-title":"Polygenic susceptibility to breast cancer: current state-of-the-art","volume":"5","author":"Ghoussaini","year":"2009","journal-title":"Future Oncol"},{"key":"2022061706060642000_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13058-016-0759-4","article-title":"The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance","volume":"18","author":"Skol","year":"2016","journal-title":"Breast Cancer Res"},{"key":"2022061706060642000_bib3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc.2016.72","article-title":"Hereditary breast and ovarian cancer: new genes in confined pathways","volume":"16","author":"Nielsen","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"2022061706060642000_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41523-017-0024-8","article-title":"The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk","volume":"3","author":"Slavin","year":"2017","journal-title":"NPJ Breast Cancer"},{"key":"2022061706060642000_bib5","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","article-title":"Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer","volume":"34","author":"Tung","year":"2016","journal-title":"J Clin Oncol"},{"key":"2022061706060642000_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature24284","article-title":"Association analysis identifies 65 new breast cancer risk loci","volume":"551","author":"Michailidou","year":"2017","journal-title":"Nature"},{"key":"2022061706060642000_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1158\/1055-9965.EPI-16-0106","article-title":"The OncoArray Consortium: a network for understanding the genetic architecture of common cancers","volume":"26","author":"Amos","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022061706060642000_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv036","article-title":"Prediction of breast cancer risk based on profiling with common genetic variants","volume":"107","author":"Mavaddat","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"2022061706060642000_bib9","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk","volume":"372","author":"Easton","year":"2015","journal-title":"N Engl J Med"},{"key":"2022061706060642000_bib10","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/jmedgenet-2017-104588","article-title":"Rare, protein-truncating variants in ATM, CHEK2 and PALB2, but not XRCC2, are associated with increased breast cancer risks","volume":"54","author":"Decker","year":"2017","journal-title":"J Med Genet"},{"key":"2022061706060642000_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.16.00066","article-title":"Breast and ovarian cancer penetrance estimates derived from germline multiple-gene sequencing results in women","author":"Kurian","year":"2017","journal-title":"JCO Precision Oncology"},{"key":"2022061706060642000_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/BD-2010-0306","article-title":"BRCA1\/2 mutations and triple negative breast cancers","volume":"32","author":"Peshkin","year":"2011","journal-title":"Breast Dis"},{"key":"2022061706060642000_bib13","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1158\/1078-0432.CCR-04-2424","article-title":"Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype","volume":"11","author":"Lakhani","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2022061706060642000_bib14","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","article-title":"Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations","volume":"90","author":"Lakhani","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"2022061706060642000_bib15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","article-title":"Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1\/2 (CIMBA)","volume":"21","author":"Mavaddat","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022061706060642000_bib16","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1093\/hmg\/ddr228","article-title":"Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium","volume":"20","author":"Broeks","year":"2011","journal-title":"Hum Mol Genet"},{"key":"2022061706060642000_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1200\/JCO.2015.63.0624","article-title":"Associations of breast cancer risk prediction tools with tumor characteristics and metastasis","volume":"34","author":"Holm","year":"2016","journal-title":"J Clin Oncol"},{"key":"2022061706060642000_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/annonc\/mdu565","article-title":"Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers","volume":"26","author":"Li","year":"2015","journal-title":"Ann Oncol"},{"key":"2022061706060642000_bib19","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1200\/JCO.2014.58.9986","article-title":"Risk factors and tumor characteristics of interval cancers by mammographic density","volume":"33","author":"Holm","year":"2015","journal-title":"J Clin Oncol"},{"key":"2022061706060642000_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41523-017-0014-x","article-title":"The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening","volume":"3","author":"Houssami","year":"2017","journal-title":"NPJ Breast Cancer"},{"key":"2022061706060642000_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ng.2563","article-title":"Large-scale genotyping identifies 41 new loci associated with breast cancer risk","volume":"45","author":"Michailidou","year":"2013","journal-title":"Nat Genet"},{"key":"2022061706060642000_bib22","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1158\/0008-5472.CAN-16-2574","article-title":"Assessment of breast cancer risk factors reveals subtype heterogeneity","volume":"77","author":"Holm","year":"2017","journal-title":"Cancer Res"},{"key":"2022061706060642000_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/joim.12303","article-title":"Review of 103 Swedish Healthcare Quality Registries","volume":"277","author":"Emilsson","year":"2015","journal-title":"J Intern Med"},{"key":"2022061706060642000_bib24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","article-title":"The Swedish cause of death register","volume":"32","author":"Brooke","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"2022061706060642000_bib25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/ije\/29.3.495","article-title":"Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics","volume":"29","author":"Johansson","year":"2000","journal-title":"Int J Epidemiol"},{"key":"2022061706060642000_bib26","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/bcr3238","article-title":"High-throughput mammographic-density measurement: a tool for risk prediction of breast cancer","volume":"14","author":"Li","year":"2012","journal-title":"Breast Cancer Res"},{"key":"2022061706060642000_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ng.3242","article-title":"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer","volume":"47","author":"Michailidou","year":"2015","journal-title":"Nat Genet"},{"key":"2022061706060642000_bib28","doi-asserted-by":"crossref","first-page":"E1200","DOI":"10.1002\/humu.21202","article-title":"Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study","volume":"31","author":"Borg","year":"2010","journal-title":"Hum Mutat"},{"key":"2022061706060642000_bib29","doi-asserted-by":"publisher","DOI":"10.1101\/052662","article-title":"Maftools: Efficient analysis, visualization and summarization of MAF files from large-scale cohort based cancer studies","author":"Mayakonda","year":"2016","journal-title":"bioRxiv"},{"key":"2022061706060642000_bib30","doi-asserted-by":"crossref","first-page":"e1003348","DOI":"10.1371\/journal.pgen.1003348","article-title":"Power and predictive accuracy of polygenic risk scores","volume":"9","author":"Dudbridge","year":"2013","journal-title":"PLoS Genet"},{"key":"2022061706060642000_bib31","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/annonc\/mdu270","article-title":"Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer","volume":"25","author":"Lindstrom","year":"2014","journal-title":"Ann Oncol"},{"key":"2022061706060642000_bib32","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/bcr1737","article-title":"Is breast cancer prognosis inherited?","volume":"9","author":"Hartman","year":"2007","journal-title":"Breast Cancer Res"},{"key":"2022061706060642000_bib33","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1634\/theoncologist.9-6-606","article-title":"Prognostic and predictive factors in early-stage breast cancer","volume":"9","author":"Cianfrocca","year":"2004","journal-title":"Oncologist"},{"key":"2022061706060642000_bib34","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1158\/1078-0432.CCR-03-1061","article-title":"Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type","volume":"10","author":"Foulkes","year":"2004","journal-title":"Clin Cancer Res"},{"key":"2022061706060642000_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10689-005-2832-5","article-title":"BRCA1 and BRCA2: chemosensitivity, treatment outcomes and prognosis","volume":"5","author":"Foulkes","year":"2006","journal-title":"Fam Cancer"},{"key":"2022061706060642000_bib36","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/jamaoncol.2017.1256","article-title":"Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy","volume":"3","author":"Cho","year":"2017","journal-title":"JAMA Oncol"},{"key":"2022061706060642000_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrclinonc.2015.203","article-title":"Breast cancer: the importance of overdiagnosis in breast-cancer screening","volume":"13","author":"Narod","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"2022061706060642000_bib38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10549-013-2612-0","article-title":"The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care","volume":"140","author":"Elson","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"2022061706060642000_bib39","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/ije\/dyw357","article-title":"Cohort profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA)","volume":"46","author":"Gabrielson","year":"2017","journal-title":"Int J Epidemiol"},{"key":"2022061706060642000_bib40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.6004\/jnccn.2009.0012","article-title":"Breast cancer. Clinical practice guidelines in oncology","volume":"7","author":"Carlson","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"2022061706060642000_bib41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000321255","article-title":"Breast Cancer Screening Program in Stockholm County, Sweden - Aspects of Organization and Quality Assurance","volume":"5","author":"Lind","year":"2010","journal-title":"Breast Care (Basel)"},{"key":"2022061706060642000_bib42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1258\/jms.2012.012085","article-title":"Mammographic screening programmes in Europe: organization, coverage and participation","volume":"19","author":"Giordano","year":"2012","journal-title":"J Med Screen"},{"key":"2022061706060642000_bib43","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1370\/afm.580","article-title":"Discovery of breast cancers within 1 year of a normal screening mammogram: how are they found?","volume":"4","author":"Carney","year":"2006","journal-title":"Ann Fam Med"},{"key":"2022061706060642000_bib44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/jcp.53.2.140","article-title":"A study of interval breast cancer within the NHS breast screening programme","volume":"53","author":"Cowan","year":"2000","journal-title":"J Clin Pathol"},{"key":"2022061706060642000_bib45","doi-asserted-by":"crossref","first-page":"e0124671","DOI":"10.1371\/journal.pone.0124671","article-title":"From benchtop to desktop: important considerations when designing amplicon sequencing workflows","volume":"10","author":"Gilbert","year":"2015","journal-title":"PLoS One"},{"key":"2022061706060642000_bib46","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1086\/421251","article-title":"CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies","volume":"74","author":"CHEK2 Breast Cancer Case-Control Consortium","year":"2004","journal-title":"Am J Hum Genet"},{"key":"2022061706060642000_bib47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41523-017-0035-5","article-title":"The WISDOM Study: breaking the deadlock in the breast cancer screening debate","volume":"3","author":"Esserman","year":"2017","journal-title":"NPJ Breast Cancer"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/78\/21\/6329\/2775720\/6329.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/78\/21\/6329\/2775720\/6329.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T13:39:06Z","timestamp":1655473146000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/78\/21\/6329\/633089\/Differential-Burden-of-Rare-and-Common-Variants-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":47,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2018,11,1]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-18-1018","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22420059","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6510549.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22420056.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22420056","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6510549","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22420059.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,1]]}}}